HealthImaging (8/1, Pearson) reports that research indicates that “despite known risks and unknown benefits, many older survivors of breast cancer with short life expectancy go for surveillance mammography every year.” Investigators also found that “relatively few with robust life expectancy don’t seem to bother.” The findings were published online in the Journal of Clinical Oncology.
Aunt Minnie (8/1, Yee) reports women who have to pay out-of-pocket “are less likely to choose digital breast tomosynthesis (DBT) over digital mammography, compared with women who have complete insurance coverage for the exam, according to a study published” in the Journal of the American College of Radiology. The researchers concluded that providers must demonstrate that DBT is worth the “additional cost to patients.”
Aunt Minnie (7/26, Yee) reports that “screening with digital breast tomosynthesis (DBT)” fails to raise “the use of BI-RADS category 3 – a designation that prompts intensive follow-up and tracking for up to two years and can provoke anxiety in patients,” a study published in Radiology says. Aunt Minnie adds “the findings are good news for women,” as “fewer BI-RADS 3 lesions translates into less uncertainty for women and potentially less healthcare costs,” according to the study’s researchers.